Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.41%
1,076.13
-15.38
-1.41%
1,091.511,090.401,090.401,073.69
SIXC
Communications
SIXC
Communications
SIXC
-0.55%
606.74
-3.37
-0.55%
610.11610.11610.29606.17
SIXE
Energy
SIXE
Energy
SIXE
+0.88%
1,248.82
+10.84
+0.88%
1,237.981,237.831,252.411,225.03
SIXI
Industrials
SIXI
Industrials
SIXI
-1.17%
1,724.36
-20.35
-1.17%
1,744.711,740.951,747.291,721.57
SIXM
Financials
SIXM
Financials
SIXM
-0.72%
635.59
-4.59
-0.72%
640.18639.92643.19634.73
SIXR
Staples
SIXR
Staples
SIXR
-0.76%
843.15
-6.43
-0.76%
849.58845.27851.68839.47
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.55%
216.29
-1.19
-0.55%
217.48217.48218.16215.51
SIXT
Technology
SIXT
Technology
SIXT
+0.08%
3,263.41
+2.72
+0.08%
3,260.693,273.363,287.813,240.78
SIXU
Utilities
SIXU
Utilities
SIXU
-0.34%
939.24
-3.21
-0.34%
942.45939.39948.80933.98
SIXV
Health care
SIXV
Health care
SIXV
-0.29%
1,462.56
-4.24
-0.29%
1,466.801,464.701,467.191,458.36
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.71%
2,380.40
-17.10
-0.71%
2,397.502,395.032,412.012,370.64
BALAXI:NSE
Balaxi Pharmaceuticals Ltd
₹26.58
-1.45%
(-0.39) 1D
May 5, 10:27:25 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BALAXI...
Open
₹26.98
High
₹27.10
Low
₹26.40
Mkt. cap
1.47B
Avg. vol.
115.16K
Volume
22.16K
P/E ratio
15.53
52-wk high
₹63.90
52-wk low
₹15.20
EPS
₹1.71
No. of employees
600
News stories
From sources across the web
About Balaxi Pharmaceuticals Ltd
CEO-
Employees600
Founded1942
Headquarters-
SectorHealth care provider
Last report
Jan 28, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -INR
Revenue / Estimate
725.42M/ (- est.)INR
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
762.66M
707.42M
561.75M
725.42M
Cost of goods sold
397.98M
395.60M
290.29M
417.35M
Cost of revenue
397.98M
395.60M
290.29M
417.35M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
239.16M
270.34M
259.77M
277.18M
Operating expense
243.77M
274.96M
264.62M
282.77M
Total operating expenses
641.74M
670.56M
554.91M
700.12M
Operating income
120.92M
36.86M
6.84M
25.30M
Other non operating income
43.84M
-17.76M
15.85M
957.00K
EBT including unusual items
96.63M
9.03M
13.77M
16.10M
EBT excluding unusual items
96.63M
9.03M
13.77M
16.10M
Income tax expense
10.25M
6.13M
11.68M
13.05M
Effective tax rate
10.61%
67.89%
84.82%
81.05%
Other operating expenses
-
-
-
-
Net income
86.38M
2.90M
2.09M
3.05M
Net profit margin
11.33%
0.41%
0.37%
0.42%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-7.36M
-10.06M
-8.92M
-10.16M
Net interest expenses
-7.36M
-10.06M
-8.92M
-10.16M
Depreciation and amortization charges
4.61M
4.62M
4.84M
5.60M
EBITDA
125.19M
41.13M
11.58M
29.57M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more